AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trial.
- DOI
- 10.2217/fon-2021-0388
- Published
- 2021 Oct
- Container
- Future oncology (London, England)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2217/fon-2021-0388,
title = {AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trial.},
author = {Mannelli F and Gianfaldoni G and Guglielmelli P and Buccisano F and Caporale R and Chiarini M and Rossi G and Venditti A and Fazi P and Crea E and Piciocchi A and Voso MT and Vignetti M and Amadori S and Vannucchi AM},
year = {2021},
journal = {Future oncology (London, England)},
doi = {10.2217/fon-2021-0388},
url = {https://doi.org/10.2217/fon-2021-0388}
}RIS
TY - JOUR TI - AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trial. AU - Mannelli F AU - Gianfaldoni G AU - Guglielmelli P AU - Buccisano F AU - Caporale R AU - Chiarini M AU - Rossi G AU - Venditti A AU - Fazi P AU - Crea E AU - Piciocchi A AU - Voso MT AU - Vignetti M AU - Amadori S AU - Vannucchi AM PY - 2021 JO - Future oncology (London, England) DO - 10.2217/fon-2021-0388 UR - https://doi.org/10.2217/fon-2021-0388 ER -
APA
F, M., G, G., P, G., F, B., R, C., M, C., G, R., A, V., P, F., E, C., A, P., MT, V., M, V., S, A., & AM, V. (2021). AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trial.. Future oncology (London, England). https://doi.org/10.2217/fon-2021-0388
Source records
- pubmed · retrieved 2026-09-27T17:19:08.642Z
- europe-pmc · retrieved 2026-09-27T17:19:08.663Z